Logo (EUIPO, 10/16/2008)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark was filed as Figurative mark on 10/16/2008 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/17/2010.
The current status of the mark is "Registration expired".
Logodesign (Wiener Klassifikation)
#Two lines or bands #Thick lines, bands #Curved lines or bands (except A 26.11.13)
| Trademark form | Figurative mark |
| File reference | 007349699 |
| Application date | October 16, 2008 |
| Publication date | December 15, 2008 |
| Entry date | May 17, 2010 |
| Expiration date | October 16, 2018 |
Trademark owner
70 East Beaver Creek Rd. Unit #30
L4B 3B2 Richmond Hill,
CA
L4B 3B2 Richmond Hill,
CA
Trademark representatives
Aurora Building, Counterslip
BS1 6BX Bristol
GB
goods and services
5
Diagnostic assays and test kits comprising diagnostic preparations for use in clinical, laboratory and chemical research and development and used to diagnose, prognose, predict or treat diseases for medical purposes; prognostic test kits comprising medical preparations for identifying disease risk factors and responses to therapeutic treatment; diagnostic preparations, including preparations of extracts, nucleic acids including RNA and cDNA clones for clinical or medical laboratory use; diagnostic preparations, including assays, and polymerase chain reaction (PCR) and real time PCR primers, proteins and antibodies, and molecular arrays of biological material for clinical or medical laboratory use; prescription pharmaceutical preparations for use in diagnosing and treating human diseases and conditions, including respiratory diseases and conditions, endocrine diseases and conditions, namely hormonal disorders, diabetes, pancreas disorders, pituitary disorders, thyroid disorders, and adrenal disorders, neurologic diseases and conditions, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, manic depression, schizophrenia, and Parkinson's disease, cardiovascular diseases and conditions, alimentary diseases and conditions, namely dyspepsia, diarrhea, and dysentery, gastrointestinal diseases and conditions, namely gastroesophogeal reflux disease, gastritis, peptic ulcers, constipation, diarrhea, gastroenteritis, irritable bowel syndrome, colitis, and Chron's disease, renal diseases and conditions, namely renal failure, nephrolithiasis, renal calcification, renal carbuncle, renal colic, and glomerular nephritis, metabolic diseases and conditions, namely diabetes, sodium metabolism disorders, calcium metabolism disorders, potassium metabolism disorders, magnesium metabolism disorders, phosphate metabolism disorders, acid-base metabolism disorders, and lysosomal storage diseases, central nervous system diseases and conditions, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, and spinal cord diseases, weight disorders, namely obesity, anorexia nervosa, and bulimia nervosa, oncologic diseases and conditions, auto-immune or imumune-related diseases and conditions, namely autoimmune diseases and immunologic deficiency syndromes, pulmonary diseases and conditions, namely chronic obstructive pulmonary disease, emphysema, asthma, and bronchitis, musculo-skeletal diseases and conditions, namely osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, osteoporosis, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries, and lymphatic diseases and conditions, namely lymphedema, lymphoma, and splenic diseases; pharmaceuticals
9
Computer storage media namely, computer tapes, computer discs and CD-Roms, providing genomic, proteomic and gene expression profile information for use in selecting therapeutics, evaluating efficacy and toxicity of treatments, evaluating treatment progression, prognosing disease or disease progression, and identifying disease heredity risk factors
10
Diagnostic kits for medical and clinical purposes
38
Computer services, namely providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics; providing access to a patient registry containing personalized health management information accessible via global, national and local computer networks
42
Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; computer services, computer tracking of databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics
44
Diagnostic services, including diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical and diagnostic services, including diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, and drug monitoring and monitoring of patient health progression, providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors; providing a website for patients and medical professionals featuring information about personalized health management, disease, and disease risk assessment services and screening products
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 16, 2019 | Extension, Trade mark expired | ||
| June 30, 2015 | Transfer / Change of address, Published | ||
| May 12, 2015 | Change Representative, Published | ||
| December 15, 2008 | Change Representative, Published |
ID: 11007349699